Expression and processing of human immunodeficiency virus type 1 gp160 using the vesicular stomatitis virus New Jersey serotype vector system

Journal of General Virology

Volumn 90, Issue 5, 2009, Pages 1135-1140

  Wu, Kunyu ^a   Kim, Gyoung Nyoun ^a   Kang, C Yong ^a  

^a WESTERN UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; GLYCOPROTEIN GP 160; GP160 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE EXPRESSION; GENE INSERTION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; VESICULAR STOMATITIS VIRUS; VIRUS RECOMBINANT; VIRUS REPLICATION; ANIMAL; CELL LINE; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; HAMSTER; METABOLISM; PHYSIOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1; VESICULAR STOMATITIS VIRUS;

ANIMALS; CELL LINE; CRICETINAE; GENE EXPRESSION REGULATION, VIRAL; GENETIC VECTORS; HIV ENVELOPE PROTEIN GP160; HIV-1; RECOMBINANT PROTEINS; VESICULAR STOMATITIS NEW JERSEY VIRUS;

EID: 67449094177     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.009019-0     Document Type: Article

References (36)

1. Abraham, G. & Banerjee, A. K. (1976). Sequential transcription of the genes of vesicular stomatitis virus. Proc Natl Acad Sci U S A 73, 1504-1508.
2. Black, B. L. & Lyles, D. S. (1992). Vesicular stomatitis virus matrix protein inhibits host cell-directed transcription of target genes in vivo. J Virol 66, 4058-4064.
3. Black, B. L., Rhodes, R. B., McKenzie, M. & Lyles, D. S. (1993). The role of vesicular stomatitis virus matrix protein in inhibition of host-directed gene expression is genetically separable from its function in virus assembly. J Virol 67, 4814-4821.
4. Black, B. L., Brewer, G. & Lyles, D. S. (1994). Effect of vesicular stomatitis virus matrix protein on host-directed translation in vivo. J Virol 68, 555-560.
5. Blondel, D., Harmison, G. G. & Schubert, M. (1990). Role of matrix protein in cytopathogenesis of vesicular stomatitis virus. J Virol 64, 1716-1725.
6. gag precursor protein. J Virol 70, 6547-6556.
7. Egan, M. A., Chong, S. Y., Rose, N. F., Megati, S., Lopez, K. J., Schadeck, E. B., Johnson, J. E., Masood, A., Piacente, P. & other authors (2004). Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 Env and SIV Gag proteins: Comparison of intranasal and intramuscular vaccination routes. AIDS Res Hum Retroviruses 20, 989-1004.
8. Ellgaard, L., Molinari, M. & Helenius, A. (1999). Setting the standards: Quality control in the secretory pathway. Science 286, 1882-1888.
9. Ellis, R. J. & Hemmingsen, S. M. (1989). Molecular chaperones: proteins essential for the biogenesis of some macromolecular structures. Trends Biochem Sci 14, 339-342.
10. Fields, B. N. & Hawkins, K. (1967). Human infection with the virus of vesicular stomatitis during an epizootic. N Engl J Med 277, 989-994.
11. Flanagan, E. B., Ball, L. A. & Wertz, G. W. (2000). Moving the glycoprotein gene of vesicular stomatitis virus to promoter-proximal positions accelerates and enhances the protective immune response. J Virol 74, 7895-7902.
12. Johnson, K. M., Vogel, J. E. & Peralta, P. H. (1966). Clinical and serological response to laboratory-acquired human infection by Indiana type vesicular stomatitis virus (VSV). Am J Trop Med Hyg 15, 244-246.
13. + cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins. J Virol 71, 5060-5068.
14. Kapadia, S. U., Rose, J. K., Lamirande, E., Vogel, L., Subbarao, K. & Roberts, A. (2005). Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine. Virology 340, 174-182.
15. Kelley, J. M., Emerson, S. U. & Wagner, R. R. (1972). The glycoprotein of vesicular stomatitis virus is the antigen that gives rise to and reacts with neutralizing antibody. J Virol 10, 1231-1235.
16. Kim, G. N. & Kang, C. Y. (2007). Matrix protein of VSV New Jersey serotype containing methionine to arginine substitutions at positions 48 and 51 allows near-normal host cell gene expression. Virology 357, 41-53.
17. LaBranche, C. C., Sauter, M. M., Haggarty, B. S., Vance, P. J., Romano, J., Hart, T. K., Bugelski, P. J., Marsh, M. & Hoxie, J. A. (1995). A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells. J Virol 69, 5217-5227.
18. Lawson, N. D., Stillman, E. A., Whitt, M. A. & Rose, J. K. (1995). Recombinant vesicular stomatitis viruses from DNA. Proc Natl Acad Sci U S A 92, 4477-4481.
19. McGettigan, J. P., Naper, K., Orenstein, J., Koser, M., McKenna, P. M. & Schnell, M. J. (2003). Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome. J Virol 77, 10889-10899.
20. McKenna, P. M., McGettigan, J. P., Pomerantz, R. J., Dietzschold, B. & Schnell, M. J. (2003). Recombinant rhabdoviruses as potential vaccines for HIV-1 and other diseases. Curr HIV Res 1, 229-237.
21. Melki, R., Gaudin, Y. & Blondel, D. (1994). Interaction between tubulin and the viral matrix protein of vesicular stomatitis virus: Possible implications in the viral cytopathic effect. Virology 202, 339-347.
22. Moulard, M. & Decroly, E. (2000). Maturation of HIV envelope glycoprotein precursors by cellular endoproteases. Biochim Biophys Acta 1469, 121-132.
23. Roberts, A., Kretzschmar, E., Perkins, A. S., Forman, J., Price, R., Buonocore, L., Kawaoka, Y. & Rose, J. K. (1998). Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge. J Virol 72, 4704-4711.
24. Roberts, A., Buonocore, L., Price, R., Forman, J. & Rose, J. K. (1999). Attenuated vesicular stomatitis viruses as vaccine vectors. J Virol 73, 3723-3732.
25. Rose, J. K. (1980). Complete intergenic and flanking gene sequences from the genome of vesicular stomatitis virus. Cell 19, 415-421.
26. Rose, J. K. & Schubert, M. (1987). Rhabdovirus genomes and their products. In The Rhabdoviruses, pp. 129-166. Edited by R. R. Wagner. New York: Plenum.
27. Rose, N. F., Roberts, A., Buonocore, L. & Rose, J. K. (2000). Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1. J Virol 74, 10903-10910.
28. Rose, N. F., Marx, P. A., Luckay, A., Nixon, D. F., Moretto, W. J., Donahoe, S. M., Montefiori, D., Roberts, A., Buonocore, L. & Rose, J. K. (2001). An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants. Cell 106, 539-549.
29. Rowell, J. F., Stanhope, P. E. & Siliciano, R. F. (1995). Endocytosis of endogenously synthesized HIV-1 envelope protein. Mechanism and role in processing for association with class II MHC. J Immunol 155, 473-488.
30. Schneider, J., Kaaden, O., Copeland, T. D., Oroszlan, S. & Hunsmann, G. (1986). Shedding and interspecies type sero-reactivity of the envelope glycopolypeptide gp120 of the human immunodeficiency virus. J Gen Virol 67, 2533-2538.
31. Schnell, M. J., Buonocore, L., Kretzschmar, E., Johnson, E. & Rose, J. K. (1996a). Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proc Natl Acad Sci U S A 93, 11359-11365.
32. Schnell, M. J., Buonocore, L., Whitt, M. A. & Rose, J. K. (1996b). The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus. J Virol 70, 2318-2323.
33. Stein, B. S. & Engleman, E. G. (1990). Intracellular processing of the gp160 HIV-1 envelope precursor. Endoproteolytic cleavage occurs in a cis or medial compartment of the Golgi complex. J Biol Chem 265, 2640-2649.
34. Villarreal, L. P., Breindl, M. & Holland, J. J. (1976). Determination of molar ratios of vesicular stomatitis virus induced RNA species in BHK21 cells. Biochemistry 15, 1663-1667.
35. Wertz, G. W., Perepelitsa, V. P. & Ball, L. A. (1998). Gene rearrangement attenuates expression and lethality of a nonsegmented negative strand RNA virus. Proc Natl Acad Sci U S A 95, 3501-3506.
36. Wertz, G. W., Moudy, R. & Ball, L. A. (2002). Adding genes to the RNA genome of vesicular stomatitis virus: Positional effects on stability of expression. J Virol 76, 7642-7650.